SkinHealth Systems Inc.
SKIN
$0.65
$0.000.71%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -8.17% | -10.02% | -13.15% | -15.34% | -17.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.17% | -10.02% | -13.15% | -15.34% | -17.97% |
| Cost of Revenue | -21.26% | -27.48% | -42.88% | -54.32% | -45.86% |
| Gross Profit | 0.90% | 3.19% | 15.96% | 62.28% | 27.55% |
| SG&A Expenses | -18.17% | -13.22% | -11.31% | -9.34% | -10.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.71% | -18.39% | -24.51% | -31.70% | -27.96% |
| Operating Income | 80.69% | 65.20% | 74.52% | 74.64% | 58.03% |
| Income Before Tax | 90.52% | 79.91% | 51.76% | 77.00% | 52.82% |
| Income Tax Expenses | 127.93% | 892.26% | -171.67% | -85.05% | -10.65% |
| Earnings from Continuing Operations | 84.28% | 67.29% | 58.31% | 77.29% | 52.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 84.28% | 67.29% | 58.31% | 77.29% | 52.18% |
| EBIT | 80.69% | 65.20% | 74.52% | 74.64% | 58.03% |
| EBITDA | 159.04% | 117.42% | 115.36% | 92.58% | 74.76% |
| EPS Basic | 83.91% | 68.08% | 58.02% | 75.54% | 49.16% |
| Normalized Basic EPS | 52.70% | 57.17% | 62.25% | 74.91% | 50.97% |
| EPS Diluted | 56.77% | 52.42% | 47.12% | 65.93% | 41.19% |
| Normalized Diluted EPS | 50.60% | 52.90% | 58.80% | 73.74% | 52.04% |
| Average Basic Shares Outstanding | 2.20% | 2.06% | 0.57% | -1.74% | -3.90% |
| Average Diluted Shares Outstanding | 2.05% | -2.83% | -4.18% | -6.24% | -4.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |